Yi He

11PUBLICATIONS
17CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Transplantation immunologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML.

|Jul 04, 2025
The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia.

Xiaoyu Zhang, Donglin Yang, Aiming Pang

|May 21, 2025
Timing of achieving MRD negativity for B-ALL patients with IKZF1 alterations in CR1 may dictate transplant decision: Autologous versus Allogeneic HSCT.

Jiali Wang, Xiaoxiao Ma, Hongye Gao

|May 09, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysis.

Wenwen Guo, Haixiao Zhang, Hongye Gao

|Apr 25, 2025
Favorable outcomes and the association between dynamic transfusion dependence and IPSS-M in MDS-h and MDS-LB patients undergoing allo-HSCT.

Wenjing Guo, Jia Li, Hui Wang

|Mar 03, 2025
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis.

Sisi Zhen, Li Liu, Xiaoyu Zhang

Pageof 2

Frequent Collaborators

9 joint publications

Donglin Yang

9 joint publications

Erlie Jiang

6 joint publications

Mingzhe Han

4 joint publications

Sizhou Feng